Rossari Biotech Reports Q1 Results Amid Group Restructuring and ESOP Allotment
Rossari Biotech Limited, during its Board of Directors meeting on July 18, 2026, announced key outcomes including unaudited financial results for the quarter ending June 30, 2026, a significant corporate restructuring move, and an update on its employee stock option plan.The company's board reviewed and approved the consolidated and standalone unaudited financial results for the recently concluded quarter. These results were subjected to Limited Review by the Statutory Auditors of the Company.Financial Performance Overview (Q1 FY 2026)
Consolidated Results:
The consolidated statements showed strong performance for the group during the quarter ended June...